Download this entire issue or browse individual articles by title below.
 |
| Front Cover |
| Front Cover | ||
| 1 | Letter from the MAPS President | Rick Doblin, Ph.D. |
| 2 | Table of Contents | |
| 3 | MDMA Neurotoxicity Research: Methodological Concerns | Charles Grob, M.D. |
| 4 | MDMA Neurotoxicity Discussed | Rick Doblin, Ph.D. |
| 6 | MDMA and Memory Impairment: Proven or Not Proven? | K. Thomas Nelson, Ph.D. |
| 9 | Reviewing the Latest Research with MDMA and MDE: Introduction to a recent MAPS organized conference | |
| 11 | Proposal for a Study with MDMA and Post Traumatic Stress Disorder in Spain | Jose Carlos Bouso Saiz |
| 15 | MDMA in a Couple Struggling with Cancer: Two Years Later | Sue |
| 18 | Cannabis in Migraine Treatment Project Moves Closer to FDA Approval | Ethan Russo, M.D. |
| 19 | MAPS Succeeds in Securing an Orphan Drug Designation for Marijuana | Rick Doblin, Ph.D. |
| 20 | Medical Cannabis Potency Testing | Dale Gieringer, Ph.D. |
| 23 | Do Entheogen-Induced Mystical Experiences Boost the Immune System? | Thomas B. Roberts, Ph.D. |
| 32 | Back Cover |